AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

MSN Sita-M 100/1000 Tablet ER

Prescription Icon
Prescription Required

Marketer

MSN Laboratories

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview MSN Sita-M 100/1000 Tablet ER

Diabex Duo 100/1000 ER tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Diabex Duo 100/1000 ER may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and existing medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time, maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to your doctor's dietary and exercise plan is crucial for successful diabetes management, as lifestyle significantly influences glycemic control. Common side effects include nausea, vomiting, diarrhea, stomach upset, headache, and sore throat. Hypoglycemia is a potential risk, particularly when combined with insulin or sulfonylureas; learn to identify and manage this complication. This medication isn't suitable for all patients. Inform your physician of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Interaction with other medications is possible; disclose all current medications to ensure safety. Alcohol should be limited due to its potential to lower blood sugar. Your doctor will monitor your kidney function and blood glucose levels throughout your treatment.

Uses of MSN Sita-M 100/1000 Tablet ER

Managing Type 2 Diabetes

Major Benefits of MSN Sita-M 100/1000 Tablet ER:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume the Sita-M 100/1000 Extended-Release tablet with a meal.

Common Side effects of MSN Sita-M 100/1000 Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use MSN Sita-M 100/1000 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not chew, crush, or divide it. Consume Sita-M 100/1000 mg Extended Release tablets with a meal.

How MSN Sita-M 100/1000 Tablet ER works:

Sita-M 100/1000 ER tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and MSN Sita-M 100/1000 Tablet ER is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Sita-M 100/1000 mg tablets (MSN) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards prior to any prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Sita-M 100/1000 mg tablet is likely not safe for breastfeeding mothers. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use the extended-release MSN Sita-M 100/1000 tablet cautiously, as dosage modification may be necessary. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Extended-release Sita-M 100/1000 mg tablets (MSN) are likely contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is advised.

What if you forget to take MSN Sita-M 100/1000 Tablet ER :

Should you forget to take a dose of your MSN Sita-M 100/1000 ER Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About MSN Sita-M 100/1000 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on MSN Sita-M 100/1000 Tablet ER

MSN Sita-M 100/1000 Tablet ER combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of MSN Sita-M 100/1000 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
MSN Sita-M 100/1000 Tablet ER may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
MSN Sita-M 100/1000 Tablet ER is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and MSN Sita-M 100/1000 Tablet ER is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Yes, MSN Sita-M 100/1000 Tablet ER can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid. Also known as Metformin-associated lactic acidosis (MALA), this rare side effect necessitates avoiding this medication in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Sitagliptin + Metformin immediately and seek medical attention.
MSN Sita-M 100/1000 Tablet ER combines sitagliptin and metformin to manage type 2 diabetes in adults. It improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
MSN Sita-M 100/1000 Tablet ER may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to MSN Sita-M 100/1000 Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and MSN Sita-M 100/1000 Tablet ER is unsafe and may heighten the risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a possible, though rare, side effect of MSN Sita-M 100/1000 Tablet ER. This condition results from excessive lactic acid in the bloodstream. Because of this risk, the medication is avoided in patients with kidney disease, older adults, and heavy alcohol users. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience any of these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of MSN Sita-M 100/1000 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues such as numbness, tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
MSN Sita-M 100/1000 Tablet ER combines sitagliptin and metformin to treat type 2 diabetes in adults. It helps control blood sugar levels when used with a healthy diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not for use in individuals under 18.
MSN Sita-M 100/1000 Tablet ER may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to MSN Sita-M 100/1000 Tablet ER components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and MSN Sita-M 100/1000 Tablet ER is unsafe due to the increased risk of lactic acidosis.
Metformin, a component of MSN Sita-M 100/1000 Tablet ER, can cause lactic acidosis, a serious, potentially fatal buildup of lactic acid in the blood (also known as MALA – Metformin-associated lactic acidosis). This rare but serious side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of MSN Sita-M 100/1000 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
MSN Sita-M 100/1000 Table...
172